Processa Pharmaceuticals, Inc. (PCSA) - Total pendapatan perusahaan

Processa Pharmaceuticals (PCSA) is modernizing legacy molecules to accelerate the market launch of breast cancer therapies. Anticipation of primary clinical trial results will serve as a key trigger, as current expenditures are already priced in. Robotic analysis of chemical properties optimizes the workflow for scientists. The company's commercial realization volumes on the GURU.Markets chart show that the 0.00 level acts as a critical mark.

Processa Pharma (PCSA) - Pendapatan perusahaan saka 04.07.2022 nganti 13.11.2026

Rincian analitis perusahaan Processa Pharmaceuticals

- nilai saham lan prakiraan konsensus rega:

Kutipan saham Processa Pharma|PCSA - Prakiraan konsensus analis

- indikator kapitalisasi pasar:

Nilai pasar Processa Pharmaceuticals, Inc.|PCSA - Nilai Total Perusahaan

- indikator nilai buku ekuitas:

Nilai Akuntansi Saham Processa Pharmaceuticals|PCSA - Nilai Buku Perusahaan|Kapitalisasi Pasar marang Aset Bersih processapharmaceuticals.com|PCSA - Aset Agregat Perusahaan

- data liabilitas lan likuiditas perusahaan:

Rasio Kabeh Utang marang Dana Pribadi Processa Pharmaceuticals|PCSA - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang modal Processa Pharma|PCSA - Gunggung utang perusahaan|Utang marang nilai buku Processa Pharmaceuticals, Inc.|PCSA - Utang jangka dawa perusahaan|Utang jangka cendhak Processa Pharmaceuticals|Koefisien jangkoan perantara processapharmaceuticals.com

- indikator bathi lan kelipatan valuasi:

PCSA - Bathi resik perusahaan|Prakiraan bathi perusahaan Processa Pharmaceuticals|PCSA - Pangali P/E|Pangali Forward P/E Processa Pharma|PCSA - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Processa Pharmaceuticals, Inc.|PCSA - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Processa Pharmaceuticals|PCSA - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan processapharmaceuticals.com|PCSA - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Processa Pharmaceuticals

- indikator volume dodolan lan pendapatan:

PCSA - Pendapatan perusahaan|Pendapatan mangsa ngarep perusahaan Processa Pharma|PCSA - Rasio rega marang pendapatan|Multiplikator forward rega marang pendapatan Processa Pharmaceuticals, Inc.

Ringkesan analisis perusahaan:PCSA processapharmaceuticals.com

Barang unggulan Processa Pharmaceuticals, Inc.

The stability of Processa Pharmaceuticals (PCSA) is driven by the efficiency of implementing software robots into oncology diagnostics. Mathematically, this trend is reflected through the summation of daily cash inflows that constitute total revenue. This metric measures real market demand for automation technologies, reaching a current value of 0.00. An analysis of the company's sales levels allows for an assessment of the risk of asset overheating when buying at historical highs.

Pesaing wigati